Basic Information
Fiasp
Regulatory Information
EMEA/H/C/004046
Authorised
January 9, 2017
November 10, 2016
8
September 23, 2021
Company Information
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
Overview Summary
Fiasp is a medicine that is used to treat children from one year of age and adults with diabetes. It contains the active substance insulin aspart, a rapid-acting insulin.